Effects of chronic oral treatment with imidapril and TCV-116 on the responsiveness to angiotensin II in ventrolateral medulla of SHR

Journal of Hypertension

Volumn 17, Issue 7, 1999, Pages 917-922

  Tsuchihashi, Takuya ^a   Kagiyama, Shuntaro ^a   Matsumura, Kiyoshi ^a   Abe, Isao ^a   Fujishima, Masatoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Anti hypertensive treatment; Blood pressure; Receptors; SHR; Ventrolateral medulla

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN II ANTAGONIST; CANDESARTAN HEXETIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMIDAPRIL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRAIN STEM; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; LONG TERM CARE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0033024799     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917070-00007     Document Type: Article

References (24)

1. 1 Muratani H, Averill DB, Ferrario CM. Effect of angiotensin II in ventrolateral medulla of spontaneously hypertensive rats. Am J Physiol 1991; 260:R977-R984.
2. 2 Muratani H, Ferrario CM, Averill DB. Ventrolateral medulla in spontaneously hypertensive rats: role of angiotensin II. Am J Physiol 1993; 264:R388-R395.
3. 3 Averill DB, Tsuchihashi T, Khosla MC, Ferrario CM. Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla. Brain Res 1994; 665:245-252.
4. 4 Sasaki S, Dampney RAL. Tonic cardiovascular effects of angiotensin II in the ventrolateral medulla. Hypertension 1990; 15:274-283.
5. 5 Hirooka Y, Potts PD, Dampney RAL. Role of angiotensin II receptor subtypes in mediating the sympathoexcitatory effects of exogenous and endogenous angiotensin peptides in the rostral ventrolateral medulla of the rabbit. Brain Res 1997; 772:107-114.
6. 6 Zimmerman MB, Barclay BW, Lehmann M, Norman JA. Effects of chronic administration of angiotensin converting enzyme (ACE) inhibitors on blood pressure and tissue ACE activity in the SHR. Clin Exp Hypertens 1987; A9:473-476.
7. 7 Jouquey S, Mathieu M-N, Hamon G, Chevillard C. Effect of chronic treatment with trandolapril or enalapril on brain ACE activity in spontaneously hypertensive rats. Neuropharmacology 1995; 34:1689-1692.
8. 8 Veltmar A, Gohlke P, Unger T. From tissue angiotensin converting enzyme inhibition to antihypertensive effect. Am J Hypertens 1991; 4:263S-269S.
9. 9 Yamada Y, Endo M, Kohno M, Suzuki T, Otsuka M, Takaiti O. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. Drug Res 1992; 42:475-482.
10. 10 Tsuchihashi T, Kagiyama S, Ohya Y, Abe I, Fujishima M. Antihypertensive treatment and the responsiveness to glutamate in ventrolateral medulla. Hypertension 1998; 31:73-76.
11. 11 Cheung HS, Cushman DW. Inhibition of homogenous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca. Biochem Biophys Acta 1973; 293:451-463.
12. 12 Gehlert DR, Gackenheimer SL, Schober DA. Autoradiographic localization of subtypes of angiotensin II antagonist binding in the rat brain. Neuroscience 1991; 44:501-514.
13. 13 Song K, Allen AM, Paxinos G, Mendelsohn FAO. Mapping of angiotensin II receptor subtype heterogeneity in rat brain. J Comp Neurol 1992; 316:467-484.
14. 14 Aldred GP, Chai SY, Song K, Zhuo J, MacGregor DP, Mendelsohn FAO. Distribution of angiotensin II receptor subtypes in the rabbit brain. Regul Pept 1993; 44:119-130.
15. 15 Saigusa T, Iriki M, Arita J. Brain angiotensin II tonically modulates sympathetic baroreflex in rabbit ventrolateral medulla. Am J Physiol 1996; 271:H1015-H1021.
16. 16 Zhu D-N, Moriguchi A, Mikami H, Higaki J, Ogihara T. Central amino acids mediate cardiovascular response to angiotensin II in the rat. Brain Res Bull 1998; 45:189-197.
17. 17 Kohara K, Mikami H, Okuda N, Ogihara T. Peripheral vs. central blockade of the renin-angiotensin system in spontaneously hypertensive rats: comparison of novel AT1 receptor antagonist TCV-116 with angiotensin converting enzyme inhibitor delapril. Hypertens Res 1993; 16:239-246.
18. 18 DePasquale MJ, Fossa AA, Holt WF, Mangiapane ML. Central DuP 753 does not lower blood pressure in spontaneously hypertensive rats. Hypertension 1992; 19:668-671.
19. 19 Chevillard C, Niwa M, Saavedra JM. Angiotensin-converting enzyme in discrete forebrain areas of spontaneously hypertensive rats. Brain Res 1984; 309:389-392.
20. 20 Zini S, Masdehors P, Lenkei Z, Fournie-Zaluski M-C, Roques BP, Corvol P, et al. Aminopeptidase A: distribution in rat brain nuclei and increased activity in spontaneously hypertensive rats. Neuroscience 1997; 78:1187-1193.
21. 21 Unger T, Ganten D, Lang RE. Tissue converting enzyme and cardiovascular actions of converting enzyme inhibitors. J Cardiovasc Pharmacol 1986; 8(suppl. 10):S75-S81.
22. 22 Nazarali AJ, Gutkind JS, Correa MA, Saavedra JM. Decreased angiotensin II receptors in subfornical organ of spontaneously hypertensive rats after chronic antihypertensive treatment with enalapril. Am J Hypertens 1990; 3:59-61.
23. 23 Tsuchihashi T, Abe I, Fujishima M. Role of metabotropic glutamate receptors in ventrolateral medulla of hypertensive rats. Hypertension 1994; 24:648-652.
24. 24 Tsuchihashi T, Kagiyama S, Onaka U, Abe I. Fujishima M. Pressor and sympathetic responses to excitatory amino acids are not augmented in the ventrolateral medulla of Dahl salt-sensitive rats. Brain Res 1997; 750:195-200.